Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol. - Toh TB; Thng DKH; Bolem N; Vellayappan BA; Tan BWQ; Shen Y; Soon SY; Ang YLE; Dinesh N; Teo K; Nga VDW; Low SW; et al. (PloS one, 2024)